Fig. 1.
Fig. 1. Nucleoside cytotoxicity on B-CLL cells. / (A) B-CLL cells were treated with 2CdA (▪), CaFdA (■), F-Ara-A (●), and dAdo (○) at 10 μmol/L for the indicated time points. Viability was assessed by counting the cells after staining with erythrosin B and is represented as percentage of the control. (B) The same cells were tested for mitochondria membrane potential by flow cytometry analysis of incorporation of DiOC6. (C) Cells were lysed in caspase buffer and incubated with 100 μmol/L of fluorometric substrate, and caspase-9 activity was measured by fluorometric analysis. (D) Caspase-3 enzymatic activity. These data (± SD) were obtained from a single patient studied in duplicate and are representative of 6 different patients.

Nucleoside cytotoxicity on B-CLL cells.

(A) B-CLL cells were treated with 2CdA (▪), CaFdA (■), F-Ara-A (●), and dAdo (○) at 10 μmol/L for the indicated time points. Viability was assessed by counting the cells after staining with erythrosin B and is represented as percentage of the control. (B) The same cells were tested for mitochondria membrane potential by flow cytometry analysis of incorporation of DiOC6. (C) Cells were lysed in caspase buffer and incubated with 100 μmol/L of fluorometric substrate, and caspase-9 activity was measured by fluorometric analysis. (D) Caspase-3 enzymatic activity. These data (± SD) were obtained from a single patient studied in duplicate and are representative of 6 different patients.

Close Modal

or Create an Account

Close Modal
Close Modal